Terms: = Gastric cancer AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Staging
2191 results:
1. Preoperatively predicting the lymph node metastasis and prognosis for gastric cancer patients.
Wang D; Wang Y; Dong L; Zhang X; Du J
Sci Rep; 2024 May; 14(1):11213. PubMed ID: 38755185
[TBL] [Abstract] [Full Text] [Related]
2. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract] [Full Text] [Related]
3. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Kroese TE; Bronzwaer S; van Rossum PSN; Schoppman SF; Deseyne PRAJ; van Cutsem E; Haustermans K; Nafteux P; Thomas M; Obermannova R; Mortensen HR; Nordsmark M; Pfeiffer P; Elme A; Adenis A; Piessen G; Bruns CJ; Lordick F; Gockel I; Moehler M; Gani C; Liakakos T; Reynolds JV; Morganti AG; Rosati R; Castoro C; Cellini F; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; van Berge Henegouwen MI; Hulshoff MCCM; van Dieren J; Vollebergh M; van Sandick JW; Jeene P; Muijs C; Slingerland M; Voncken FEM; Hartgrink H; Creemers GJ; van der Sangen MJC; Nieuwenhuijzen GAP; Berbee M; Verheij M; Wijnhoven B; Beerepoot LV; Mohammad NH; Mook S; Ruurda JP; Kolodziejczyk P; Polkowski WP; Wyrwicz L; Alsina M; Tabernero J; Pera M; Kanonnikoff TF; Cervantes A; Nilsson M; Monig S; Wagner AD; Guckenberger M; Griffiths EA; Smyth E; Hanna GB; Markar S; Chaudry MA; Hawkins MA; Cheong E; van Laarhoven HWM; van Hillegersberg R;
Eur J Cancer; 2024 Jun; 204():114062. PubMed ID: 38678762
[TBL] [Abstract] [Full Text] [Related]
4. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
5. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
6.
Zhang S; Hu Q; Chen X; Zhou N; Huang Q; Tan S; Su M; Gou H
BMJ Open; 2024 Apr; 14(4):e075680. PubMed ID: 38643004
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer: a meta-analysis.
Zhong Y; Xiao YY; Ye JY; Jian GL; Huang WJ
BMC Cancer; 2024 Apr; 24(1):422. PubMed ID: 38580944
[TBL] [Abstract] [Full Text] [Related]
8. Surgical options and survival prognosis in geriatric patients beyond average lifespan with locally advanced gastric cancer: a propensity score-matched analysis.
Tian Z; Xia M; Cheng Y; Zhou J; Li R; Zhao S; Sun Q; Wang D
Surg Endosc; 2024 May; 38(5):2756-2769. PubMed ID: 38575830
[TBL] [Abstract] [Full Text] [Related]
9. Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies.
Ruby L; Jayaprakasam VS; Fernandes MC; Paroder V
Hematol Oncol Clin North Am; 2024 Jun; 38(3):711-730. PubMed ID: 38575457
[TBL] [Abstract] [Full Text] [Related]
10. Impact of
de Jongh C; van der Meulen MP; Gertsen EC; Brenkman HJF; van Sandick JW; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; Daams F; van der Peet DL; van Grieken NCT; Heisterkamp J; van Etten B; van den Berg JW; Pierie JP; Eker HH; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; Wevers KP; Hol L; Wessels FJ; Haj Mohammad N; Frederix GWJ; van Hillegersberg R; Siersema PD; Vegt E; Ruurda JP;
Ann Surg Oncol; 2024 Jun; 31(6):4005-4017. PubMed ID: 38526832
[TBL] [Abstract] [Full Text] [Related]
11. Peritoneal Tumor DNA as a Prognostic Biomarker in gastric cancer: A Systematic Review and Meta-Analysis.
Allan Z; Witts S; Wong DJ; Lee MM; Tie J; Tebbutt NC; Clemons NJ; Liu DS
JCO Precis Oncol; 2024 Mar; 8():e2300546. PubMed ID: 38513167
[TBL] [Abstract] [Full Text] [Related]
12. Superior lymph node harvest by fluorescent lymphography during minimally invasive gastrectomy for gastric cancer patients with high body mass index.
Kim KY; Hwang J; Park SH; Cho M; Kim YM; Kim HI; Hyung WJ
Gastric Cancer; 2024 May; 27(3):622-634. PubMed ID: 38502275
[TBL] [Abstract] [Full Text] [Related]
13. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
[TBL] [Abstract] [Full Text] [Related]
14. [A Case of Conversion Surgery for Stage Ⅳ ATP-Producing gastric cancer with Distant Metastasis].
Egami Y; Sugimura K; Katsuyama S; Masuzawa T; Yanagisawa K; Kinoshita M; Ikeshima R; Shinke G; Hiraki M; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):329-331. PubMed ID: 38494821
[TBL] [Abstract] [Full Text] [Related]
15. Adjuvant treatment for locally advanced gastric cancer: an Asian perspective.
Kim HD; Ryu MH; Kang YK
Gastric Cancer; 2024 May; 27(3):439-450. PubMed ID: 38489111
[TBL] [Abstract] [Full Text] [Related]
16. Impact of endoscopic surveillance on the early diagnosis and endoscopic resection likelihood of gastric cancer.
Sun L; Shen Y; Huang L; Zhao J; Li M; Hu Y; Lyu B
Surg Endosc; 2024 Apr; 38(4):2188-2196. PubMed ID: 38448623
[TBL] [Abstract] [Full Text] [Related]
17. Patient metabolic profile defined by liver and muscle
Vitiello GA; Jayaprakasam VS; Tang LH; Schattner MA; Janjigian YY; Ku GY; Maron SB; Schoder H; Larson SM; Gönen M; Datta J; Coit DG; Brennan MF; Strong VE
Gastric Cancer; 2024 May; 27(3):548-557. PubMed ID: 38436762
[TBL] [Abstract] [Full Text] [Related]
18. The role of mir96 in predicting CTC status and prognostic evaluation in gastric cancer patients.
Zheng Q; Ge H
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):264-274. PubMed ID: 38430012
[TBL] [Abstract] [Full Text] [Related]
19. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
[TBL] [Abstract] [Full Text] [Related]
20. The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study.
van Hootegem SJM; Chmelo J; van der Sluis PC; Lagarde SM; Phillips AW; Wijnhoven BPL
Eur J Surg Oncol; 2024 Apr; 50(4):108233. PubMed ID: 38428107
[TBL] [Abstract] [Full Text] [Related]
[Next]